TRANS-4'-HYDROXYGLIPIZIDE
UNII 3R9UDL8BU8

Substance Identification & Data

This profile provides standardized clinical and technical data for Trans-4'-hydroxyglipizide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3R9UDL8BU8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 38207-36-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3R9UDL8BU8

CAS Registry Number

38207-36-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TRANS-4'-HYDROXYGLIPIZIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H27N5O5S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WPQWQJBFAJEUHS-QAQDUYKDSA-N

Line notation for describing the chemical structure and connectivity of atoms.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

S(NC(N[C@H]1CC[C@@H](CC1)O)=O)(=O)(=O)c2ccc(cc2)CCNC(=O)c3cnc(cn3)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trans-4'-hydroxyglipizide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.